<p>(A) Average anti-Pfs25 IgG titers from mice immunized with two doses of either 1.0 µg (circles) or 0.1 µg (squares) of Pfs25-CP VLPs, each with (open symbols) or without (filled symbols) Alhydrogel®, or 5.0 µg of CP only (black line). (B) Average anti-Pfs25 IgG titers from mice immunized with two doses of either 1.0 µg (circles), 0.1 µg (squares) or 0.01 µg (diamonds) of Pfs25-CP VLPs with Alhydrogel®. (C) Average anti-Pfs25 IgG titers elicited by a single administration of Pfs25-CP VLPs with Alhydrogel® at antigen doses ranging from 0.2–25 µg. Data are represented as average values per group of mice ± standard error of the mean.</p
<p>(A) Immunization regimen for evaluation of route of administration. ELISA plates were coated with...
<p>ELISA was carried out with sera from mice immunized with the PE25, PPE41 and PE25/PPE41 recombina...
<p>Data represent the p24 specific IgG titer at D0, D13, D27 and D42. The IgG values represent the a...
<p>BALB/c mice were immunized with Ad-MVA Pfs25 as in <a href="http://www.plosone.org/article/info:d...
<p><i>(A)</i> BALB/c mice were immunized with Ad-MVA Pfs25 (AdHu5 Pfs25 prime, MVA Pfs25 boost). Tot...
<p>ELISA plates were coated with 2 μg/ml VLPs, gp120 Env, or Pr55 Gag. IgG1 quantitative ELISA of po...
<p>Mice were immunized twice at study weeks 0 and 3 with 3, 10 and 30 µg of single antigens and the ...
<p>Immune sera collected on Day 42 (left panel) or 70 (right panel) were analyzed by ELISA. Vaccinat...
BALB/c mice (n = 10/group) were immunized i.m. with HBsAg (2 μg) with or without adjuvant on days 0 ...
<p>The same amount of human IgGs (500 µg) as used in the challenge studies were administered via i.p...
<p>Infant and adult mice (<i>n</i> = 16–20/group) were immunized with PBS or <i>S</i>. Enteritidis C...
<p>BALB/c mice (n = 10) were immunized with Ad-MVA Pfs25 and infected with Pfs25DR3 as previously (<...
<p>(<b>A–D</b>) Therapeutic protocol. (<b>E–H</b>) Preventative protocol. (<b>A</b>) and (<b>E</b>) ...
<p>Total IgG titres, calculated in comparison to a pooled standard serum, were determined for sera f...
<p>Immune sera were collected from Day 42 after two vaccinations were analyzed. Dose: 0.5 μg/mouse.<...
<p>(A) Immunization regimen for evaluation of route of administration. ELISA plates were coated with...
<p>ELISA was carried out with sera from mice immunized with the PE25, PPE41 and PE25/PPE41 recombina...
<p>Data represent the p24 specific IgG titer at D0, D13, D27 and D42. The IgG values represent the a...
<p>BALB/c mice were immunized with Ad-MVA Pfs25 as in <a href="http://www.plosone.org/article/info:d...
<p><i>(A)</i> BALB/c mice were immunized with Ad-MVA Pfs25 (AdHu5 Pfs25 prime, MVA Pfs25 boost). Tot...
<p>ELISA plates were coated with 2 μg/ml VLPs, gp120 Env, or Pr55 Gag. IgG1 quantitative ELISA of po...
<p>Mice were immunized twice at study weeks 0 and 3 with 3, 10 and 30 µg of single antigens and the ...
<p>Immune sera collected on Day 42 (left panel) or 70 (right panel) were analyzed by ELISA. Vaccinat...
BALB/c mice (n = 10/group) were immunized i.m. with HBsAg (2 μg) with or without adjuvant on days 0 ...
<p>The same amount of human IgGs (500 µg) as used in the challenge studies were administered via i.p...
<p>Infant and adult mice (<i>n</i> = 16–20/group) were immunized with PBS or <i>S</i>. Enteritidis C...
<p>BALB/c mice (n = 10) were immunized with Ad-MVA Pfs25 and infected with Pfs25DR3 as previously (<...
<p>(<b>A–D</b>) Therapeutic protocol. (<b>E–H</b>) Preventative protocol. (<b>A</b>) and (<b>E</b>) ...
<p>Total IgG titres, calculated in comparison to a pooled standard serum, were determined for sera f...
<p>Immune sera were collected from Day 42 after two vaccinations were analyzed. Dose: 0.5 μg/mouse.<...
<p>(A) Immunization regimen for evaluation of route of administration. ELISA plates were coated with...
<p>ELISA was carried out with sera from mice immunized with the PE25, PPE41 and PE25/PPE41 recombina...
<p>Data represent the p24 specific IgG titer at D0, D13, D27 and D42. The IgG values represent the a...